Cellanome
Live-cell imaging platform integrated with single-cell transcriptomics and CellCage cell-tracking technology
- Sector
- Biotech
- Headquarters
- Palo Alto, CA
- Founded
- 2020
- Latest Form D
- $75.9M, Jun 2026
- Total capital
- $279M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $279M
- 5 Form D · last Jun 2026
- 4 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 14
- 26 pending · first 2023
- Rank in peer group#18 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$75.9M
- Private capital raisedForm D · SEC · 4th filing$150M
- Private capital raisedForm D · SEC · 3rd filing$30M
- Private capital raisedForm D · SEC · 2nd filing$21M
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#18 · top 5%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Ali AgahExecutive Officer, DirectorNamed in SEC Form D filings
- Jay FlatleyDirectorNamed in SEC Form D filings
- Kazutaka OhnoExecutive OfficerNamed in SEC Form D filings
- Mehdi KhodadadExecutive OfficerNamed in SEC Form D filings
- Mostafa Kumar RonaghiDirectorNamed in SEC Form D filings
- Omead Kumar OstadanDirectorNamed in SEC Form D filings
Show all 10 people
- Rowan ChapmanDirectorNamed in SEC Form D filings
- Sandesh PatnamDirectorNamed in SEC Form D filings
- Sue McGrathExecutive OfficerNamed in SEC Form D filings
- Tarun KhuranaExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 14 granted of 40- GrantedFlow CellUSPTOUS D1,148,123
- PendingCell Sorting And Selection Using Degradable HydrogelsUSPTOApplication 19429978
- GrantedFlow CellUSPTOUS D1,146,065
Show all 40 patent records
- Flow CellSep 15, 2026 · US D1,148,123Granted
- Cell Sorting And Selection Using Degradable HydrogelsSep 3, 2026 · Application 19429978Pending
- Flow CellSep 1, 2026 · US D1,146,065Granted
- Systems And Methods For Analyzing Tissue SamplesAug 25, 2026 · US 12,714,996Granted
- Methods For Performing Assays On Individual Live CellsJul 30, 2026 · Application 19577221Pending
- Methods For Forming Enclosures And Performing Assays On A Cell Within An EnclosureJul 23, 2026 · Application 19577281Pending
- Methods For Incubating And Analyzing A Cell In A Compartment Of A Fluidic DeviceJul 16, 2026 · Application 19538691Pending
- Systems And Methods For Analyzing Tissue SamplesJun 25, 2026 · Application 19545412Pending
- Systems And Methods For Compartmentalizing And Analyzing CellsJun 25, 2026 · Application 19545403Pending
- Methods For Enclosing And Analyzing A Cell In A Fluidic DeviceJun 23, 2026 · US 12,661,647Granted
- Methods For Immobilizing And Sorting A Cell Using LightJun 4, 2026 · Application 19459949Pending
- Systems And Methods For Removing Cells From Fluidic DevicesMay 7, 2026 · Application 19376703Pending
- Methods For Performing Assays On Individual Live CellsApr 30, 2026 · Application 19381382Pending
- Devices And Methods For Analyzing Biological SamplesApr 14, 2026 · US 12,600,817Granted
- Methods For Incubating And Analyzing A Cell In A Compartment Of A Fluidic DeviceMar 17, 2026 · US 12,576,400Granted
- Methods For Imaging And Analyzing A Cell In A Compartment Of A Fluidic DeviceMar 17, 2026 · US 12,576,399Granted
- Methods For Detecting Intercellular Interactions Of Cells In A Compartment Of A Fluidic DeviceMar 10, 2026 · US 12,569,847Granted
- Cell Sorting And Selection Using Degradable HydrogelsFeb 17, 2026 · US 12,553,819Granted
- Spatially Barcoded SurfacesOct 16, 2025 · Application 19252879Pending
- Devices And Methods For Analyzing Biological SamplesOct 14, 2025 · US 12,440,837Granted
- Liquid Delivery SystemAug 14, 2025 · Application 19189056Pending
- Single Cell Proteomics Using Degradable HydrogelsMay 22, 2025 · Application 19030206Pending
- Devices And Methods For Analyzing Biological SamplesMay 20, 2025 · US 12,303,892Granted
- Method Of Constructing A Spatially Barcoded SurfaceMay 8, 2025 · Application 18952420Pending
- Spatial Barcodes By Hydrogel LithographyFeb 13, 2025 · Application 18908638Pending
- Multiplex Cellular Assays For Screening And Quality Assessment Of Engineered CellsJan 23, 2025 · Application 18891555Pending
- Methods For Analyzing Biological Samples In A Fluidic Device Comprising Generating A Polymer Matrix From Precursors At Specific Locations Comprising Biological ComponentsNov 26, 2024 · US 12,151,242Granted
- Systems And Methods For Analyzing Biological SamplesSep 12, 2024 · Application 18534328Pending
- Methods For Analyzing Biological Samples In A Fluidic Device Comprising Generating A Polymer Matrix From Precursors At Discrete AreasJul 9, 2024 · US 12,030,047Granted
- Devices And Methods For Analyzing Biological SamplesJan 17, 2023 · US 11,554,370Granted
- Devices And Methods For Analyzing Biological SamplesJan 5, 2023 · Application 17896742Pending
- Devices And Methods For Analyzing Biological SamplesJul 14, 2022 · Application 17669315Pending
- Systems And Methods For Analysis Of CellsApplication PCTUS2025061662Pending
- Analysis Of Biological Materials And Associated User InterfaceApplication PCTUS2025027625Pending
- Systems And Methods For Optimal Cage PlacementApplication PCTUS2025027630Pending
- Devices And Methods For Analyzing Biological SamplesApplication PCTUS2024059913Pending
- Systems And Methods For Analysis Of CellsApplication PCTUS2025027635Pending
- Fluidic Devices For Drug ReleaseApplication PCTUS2025052442Pending
- Fluidic Devices For Drug ReleaseApplication 63712306Pending
- Single Cell Proteomics Using Degradable HydrogelsApplication PCTUS2025012459Pending
Related companies, and why
- Harmony Biosciences II, Inc.Similar federal contract value in Biotech · null in contracts
- Dewpoint TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Neurona TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Rakuten Medical, Inc.Similar federal contract value in Biotech · null in contracts
- SeaStar Medical Holding CorpSimilar federal contract value in Biotech · null in contracts
- EvommuneSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .